Design of a novel interleukin-13 antagonist from analysis of informational structure
Interleukin-13 (IL-13) is one of the cytokines involved in the development of Th2-type immune response. It plays an important role in the pathogenesis of asthma and other allergic diseases. Two deletion forms of IL-13 were constructed on a basis of informational structure analysis and expressed in E. coli cells. They were found to differ in ability to stimulate proliferation of TF-1 cell line. Deletion variant 146 (DV146) completely lacks such activity, whereas DV148 provides about 50% of the proliferation stimulation. The simultaneous addition of DV146 with full-length IL-13 suppresses proliferation depending on the concentration of the deletion form. Thus, the designed protein acts as an antagonist of IL-13.
Key wordsANIS method informational structure deletion variant IL-13 antagonist TF-1 proliferation
analysis of informational structure
elements of informational structure
increased degree of information coordination
sites with a locally increased degree of information coordination between residues
splice overlap extension
Unable to display preview. Download preview PDF.
- 6.Akdis, M., Akdis, C. A., Weigl, L., Disch, R., and Blaser, K. (1997) J. Immnol., 159, 4611–4619.Google Scholar
- 15.Sambrook, J., and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.Google Scholar
- 16.Shingarova, L. N., Kashyap, S. K., Petrovskaya, L. E., Petrenko, L. A., Pustoshilova, N. M., Sinichkina, S. A., and Korobko, V. G. (1998) Biotekhnologiya, 6, 24–35.Google Scholar